Another earlier memantine trial – the Benefit and Efficacy in Severely Demented patients during Treatment with Memantine (M-Best or 9403) study – enrolled participants with moderately severe AD as ...
The Food and Drug Administration approved the German medication memantine today to help ease the severe symptoms of an estimated 1 million Americans who suffer from the late stages of Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results